Lifecome Biochemistry Co Ltd Total Assets
Lifecome Biochemistry Co Ltd total assets. Based on the latest financial reports, Lifecome Biochemistry Co Ltd (002868) holds total assets worth CN¥729.16 Million CNY (≈ $106.70 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 002868 company net worth for the company's overall valuation and market capitalisation.
Total Assets of Lifecome Biochemistry Co Ltd (2012–2025)
Total assets of Lifecome Biochemistry Co Ltd from 2012 to 2025. This chart illustrates how Lifecome Biochemistry Co Ltd's total assets have evolved over time, based on quarterly financial data. See Lifecome Biochemistry Co Ltd share price for real-time trading data and today's change.
Lifecome Biochemistry Co Ltd - Asset Composition Analysis
Lifecome Biochemistry Co Ltd Total Assets Breakdown (December 2025)
Lifecome Biochemistry Co Ltd total assets breakdown as of December 2025. Lifecome Biochemistry Co Ltd's total assets of CN¥729.16 Million consist of 27.7% current assets and 72.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.4% |
| Accounts Receivable | CN¥48.08 Million | 6.4% |
| Inventory | CN¥95.48 Million | 12.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥21.08 Million | 2.8% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Lifecome Biochemistry Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 002868 working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lifecome Biochemistry Co Ltd's current assets represent 27.7% of total assets in 2025, a decrease from 28.4% in 2012.
- Cash Position: Cash and equivalents constituted 7.4% of total assets in 2025, up from 4.7% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, unchanged from 2.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 12.8% of total assets.
Lifecome Biochemistry Co Ltd Competitors by Total Assets
Key competitors of Lifecome Biochemistry Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
Lifecome Biochemistry Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.37 | 0.14 | 0.77 |
| Quick Ratio | 0.20 | 0.06 | 0.56 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-346.90 Million | CN¥-1.05 Billion | CN¥-81.68 Million |
Lifecome Biochemistry Co Ltd - Advanced Valuation Insights
This section examines the relationship between Lifecome Biochemistry Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 51.48 |
| Latest Market Cap to Assets Ratio | 0.56 |
| Asset Growth Rate (YoY) | -49.8% |
| Total Assets | CN¥748.71 Million |
| Market Capitalization | $416.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values Lifecome Biochemistry Co Ltd's assets below their book value (0.56x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Lifecome Biochemistry Co Ltd's assets decreased by 49.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Lifecome Biochemistry Co Ltd (2012–2025)
The table below shows the annual total assets of Lifecome Biochemistry Co Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥748.71 Million ≈ $109.56 Million |
-49.81% |
| 2024-12-31 | CN¥1.49 Billion ≈ $218.28 Million |
-24.09% |
| 2023-12-31 | CN¥1.97 Billion ≈ $287.54 Million |
+58.49% |
| 2022-12-31 | CN¥1.24 Billion ≈ $181.43 Million |
-1.47% |
| 2021-12-31 | CN¥1.26 Billion ≈ $184.14 Million |
+29.40% |
| 2020-12-31 | CN¥972.50 Million ≈ $142.31 Million |
-3.72% |
| 2019-12-31 | CN¥1.01 Billion ≈ $147.80 Million |
+25.88% |
| 2018-12-31 | CN¥802.42 Million ≈ $117.42 Million |
+6.11% |
| 2017-12-31 | CN¥756.25 Million ≈ $110.66 Million |
+104.03% |
| 2016-12-31 | CN¥370.66 Million ≈ $54.24 Million |
-5.57% |
| 2015-12-31 | CN¥392.52 Million ≈ $57.44 Million |
+0.62% |
| 2014-12-31 | CN¥390.09 Million ≈ $57.08 Million |
-1.46% |
| 2013-12-31 | CN¥395.88 Million ≈ $57.93 Million |
+6.60% |
| 2012-12-31 | CN¥371.37 Million ≈ $54.34 Million |
-- |
About Lifecome Biochemistry Co Ltd
Lifecome Biochemistry Co.,Ltd. engages in research, development, production, and sales of veterinary drugs in China. It offers probiotics and green microbial functional additives; biopesticides, biofertilizers, and pesticide formulations; and food additives. The company was founded in 2003 and is based in Pucheng, China.